UK's Largest Cord Blood Bank
3X more stem cells at the point of therapy
Store multiple samples Your baby’s umbilical cord could change their life.
Cells4Life stores more UK stem cell samples than any other private bank. We are a science-led organisation dedicated to delivering the best stem cell storage service in the world. It contains billions of powerful stem cells, which already form therapy for more than 80 conditions worldwide, such as immune disorders and blood cancers. These stem cells are central to promising clinical trials for some of today’s most debilitating conditions – from cancer to diabetes, cerebral palsy to arthritis. In the moments after birth, you have a once-in-a-lifetime chance to save your baby’s umbilical cord blood for future therapeutic use. As the UK’s largest cord blood bank, Cells4Life helps parents to make the most of this opportunity. We were founded in 2002 by a group of leading doctors and scientists to offer stem cell collection and storage in the United Kingdom. Initially, these doctors and scientists sought to store their own children’s umbilical cord tissue and blood for future use. Now, 18 years later, we have expanded to store more than 140,000 samples for customers in over 54 countries. In January 2020, we also became the UK’s first stem cell storage bank to offer placenta banking, meaning you can choose to store cells from the placenta and cord blood to maximise the therapeutic possibilities of your baby’s sample. Cells and tissue from the placenta have been used since the early 20th century to treat burns and wounds. Now, clinical trials are investigating its use in therapies for conditions such as Crohn’s disease, diabetes, blindness, and many more. We are the UK’s largest cord blood bank and also the most experienced, having been established for more than 18 years. We have already released 13 samples, two of which have been used to treat autism and cerebral palsy. Everything we do is designed to ensure you can make the most of your child’s cord blood. That is why we also introduced our exclusive TotiCyte cord blood processing technology in 2017. With TotiCyte, we are able to preserve three times more stem cells than the industry standard AXP processing method, which powers our Cells service. Initial results from hundreds of clinical trials using cord blood stem cells have been positive and shown that they could help your child to live a longer, healthier life. They could regrow organs, treat diseases and disorders, and repair damaged tissue. Make sure your child doesn’t miss out on the future of medicine. Visit www.cells4life.com to find out more about your cord blood banking options.
12/01/2026
Current stroke treatments save lives, but there is still a significant unmet need when it comes to addressing the neurological consequences - and that's where a recent clinical trial is showing promise.
The phase 2 trial highlights the potential of mesenchymal stem cells (MSCs) from the umbilical cord to help regulate inflammation and aid tissue regeneration following an ischaemic stroke.
While larger studies are needed, the results on functional independence and improved quality of life are encouraging. Read the full breakdown of the study via the link below.
New research reveals umbilical cord stem cells may aid ischaemic stroke recovery. Discover Phase 2 trial results and the future of regenerative medicine.
08/01/2026
A new therapy based on umbilical cord stem cells for Charcot-Marie-Tooth disease, a progressive disabling condition which affects the nerves, is to begin in South Korea. The treatment aims to support and repair the myelin coat, the protective sheath of the nerves, thus reducing the impact of the disease. Hit the link below for the full article.
Phase 2a trial approved for Umbilical Cord Stem Cell therapy for Charcot-Marie-Tooth (CMT) disease. Learn about the new Wharton’s jelly MSC treatment and clinical results.
30/12/2025
A recent case study highlights how a cord blood transplant shows promise for the treatment of Lesch-Nyhan syndrome, a complex, rare condition with severe neurological effects. To learn more, follow the link below.
A recent case study highlights how an umbilical cord blood transplant shows promise for treating Lesch-Nyhan syndrome.
22/09/2025
Positive data is emerging from a Phase 2 trial for a new therapy that targets mitochondrial dysfunction. The therapy works by transplanting healthy mitochondria into stem cells to restore normal cellular function. Should it prove effective, it may also help reverse some of the effects of ageing. To learn more about the therapy, follow the link below.
A therapy based on transplanting mitochondria into blood stem cells could treat incurable diseases and help reverse the effects of ageing.
09/09/2025
Could the body’s own immune system be the key to fighting aggressive brain cancer? For Pamela Goldberger, the answer may be yes. Diagnosed with glioblastoma and given only months to live, she is now alive and well two and a half years later. She participated in a clinical trial for a novel cell therapy, and the results are showing promise. Learn more about the science behind this groundbreaking treatment though the link below.
A novel cell therapy could prove to be an effective treatment for glioblastoma, a highly aggressive brain cancer.
30/06/2025
A recent phase 1 trial has found that eye drops containing mesenchymal stem cells from the umbilical cord could help relieve the symptoms of dry eye. To learn more about this potential new treatment for this common condition, follow the link below.
A recent phase 1 trial has found that umbilical cord stem cell eye drops could help relieve the symptoms of dry eye.
02/06/2025
A six-year-old girl named Zara has become the first child in Australia to receive her own stored cord blood as treatment for cerebral palsy. To read more about this milestone, which experts hope this will pave the way towards broader availability of the treatment, hit the link in our bio.
A six-year-old girl named Zara has become the first child in Australia to receive her own stored cord blood as treatment for cerebral palsy.
27/05/2025
A recent retrospective study has offered fresh insights on cord tissue stem cell therapy for type 2 diabetes. According to researchers, the treatment could help sufferers manage the disease, stabilising blood sugar levels and reducing insulin resistance. To read more about the study, follow the link below.
A recent retrospective study offers new insights on how cord tissue stem cells could provide health benefits for type 2 diabetes patients.
22/05/2025
Researchers are investigating a novel stem cell therapy for multiple sclerosis, a currently incurable degenerative neurological condition. The therapy, based on stem cells derived from the placenta, reduced disability scores and improved neurological function in patients. To read more about the findings of the clinical trial, which were published in the prestigious journal Scientific Reports, hit the link below.
Researchers are investigating a placenta-derived stem cell therapy for multiple sclerosis, a currently incurable neurological condition.
19/05/2025
A recent clinical trial has shown that repeated injections of stem cells derived from the placenta could reduce pain and improve function for sufferers of knee osteoarthritis. To learn more about the trial and this potential new treatment, follow the link below.
A recent clinical trial has found that placenta stem cell injections are safe and could be an effective treatment for knee osteoarthritis.
30/04/2025
Preliminary results from a clinical trial indicate that a cord tissue stem cell therapy for a severe form of epidermolysis bullosa, a disorder which causes extreme skin fragility, shows promise in relieving symptoms and reducing disease activity. To learn more about this developing treatment, follow the link below.
A clinical trial testing a cord tissue stem cell therapy for epidermolysis bullosa has reported improved quality of life for patients.
25/04/2025
A newly-published review statistically demonstrates that cord blood therapy can be an effective treatment for cerebral palsy. To read in detail how cord blood could improve motor skills for children suffering from this complex condition, follow the link below.
A new review confirms cord blood therapy significantly improves motor skills in children with cerebral palsy, especially alongside rehab.
Be the first to know and let us send you an email when Cells4Life posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Your baby’s umbilical cord could change their life
It contains billions of powerful stem cells, which already form therapy for more than 80 conditions worldwide, such as immune disorders and blood cancers. These stem cells are central to promising clinical trials for some of today’s most debilitating conditions – from cancer to diabetes, cerebral palsy to arthritis.
In the moments after birth, you have a once-in-a-lifetime chance to save your baby’s umbilical cord blood for future therapeutic use. As the UK’s largest cord blood bank, Cells4Life helps parents to make the most of this opportunity.
We were founded in 2002 by a group of leading doctors and scientists to offer stem cell collection and storage in the United Kingdom. Initially, these doctors and scientists sought to store their own children’s umbilical cord tissue and blood for future use. Now, 18 years later, we have expanded to store more than 140,000 samples for customers in over 54 countries.
In January 2020, we also became the UK’s first stem cell storage bank to offer placenta banking, meaning you can choose to store cells from the placenta and cord blood to maximise the therapeutic possibilities of your baby’s sample. Cells and tissue from the placenta have been used since the early 20th century to treat burns and wounds. Now, clinical trials are investigating its use in therapies for conditions such as Crohn’s disease, diabetes, blindness and many more.
We are the UK’s largest cord blood bank and also the most experienced, having been established for more than 18 years . We have already released 13 samples, two of which have been used to treat autism and cerebral palsy.
Everything we do is designed to ensure you can make the most of your child’s cord blood. That is why we also introduced our exclusive TotiCyte cord blood processing technology in 2017. With TotiCyte, we are able to preserve three times more stem cells than the industry standard AXP processing method, which powers our Cells service.
Initial results from hundreds of clinical trials using cord blood stem cells have been positive and shown that they could help your child to live a longer, healthier life. They could regrow organs, treat diseases and disorders, and repair damaged tissue.
Make sure your child doesn’t miss out on the future of medicine. Visit www.cells4life.com to find out more about your cord blood banking options.
